Bellevue Group AG Has $1.24 Million Stake in Encompass Health Co. (NYSE:EHC)

Bellevue Group AG increased its position in shares of Encompass Health Co. (NYSE:EHC) by 25.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,980 shares of the company’s stock after purchasing an additional 3,080 shares during the period. Bellevue Group AG’s holdings in Encompass Health were worth $1,237,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Principal Securities Inc. bought a new position in Encompass Health during the 4th quarter worth $25,000. Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after acquiring an additional 317 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in Encompass Health during the 4th quarter worth $30,000. GAMMA Investing LLC bought a new stake in Encompass Health during the 4th quarter worth $33,000. Finally, Parallel Advisors LLC grew its position in Encompass Health by 192.3% during the 4th quarter. Parallel Advisors LLC now owns 573 shares of the company’s stock worth $38,000 after acquiring an additional 377 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Encompass Health

In related news, insider Elissa Joy Charbonneau sold 10,000 shares of the stock in a transaction on Friday, May 24th. The stock was sold at an average price of $85.02, for a total value of $850,200.00. Following the transaction, the insider now owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the transaction, the insider now directly owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP John Patrick Darby sold 14,543 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the sale, the executive vice president now directly owns 84,773 shares in the company, valued at $7,115,845.62. The disclosure for this sale can be found here. Insiders have sold a total of 69,519 shares of company stock valued at $5,816,091 over the last 90 days. 2.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

EHC has been the topic of several recent research reports. Raymond James reaffirmed a “strong-buy” rating and set a $95.00 target price (up from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Barclays lifted their target price on Encompass Health from $108.00 to $113.00 and gave the stock an “overweight” rating in a report on Wednesday, July 10th. Mizuho lifted their target price on Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Truist Financial boosted their price objective on Encompass Health from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, July 15th. Finally, Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $96.50.

Encompass Health Stock Down 0.1 %

EHC traded down $0.06 during midday trading on Monday, reaching $91.55. 417,566 shares of the company were exchanged, compared to its average volume of 628,021. The company has a market cap of $9.22 billion, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 1.43 and a beta of 0.89. The company’s fifty day moving average price is $85.59 and its 200 day moving average price is $80.30. Encompass Health Co. has a one year low of $57.55 and a one year high of $92.45. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Tuesday, October 1st. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. Encompass Health’s dividend payout ratio (DPR) is 16.22%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.